Federico Ravaioli

机构：Azienda USL di Bologna, University of Bologna · ORCID：0000-0002-1142-8585

发表论文 234 篇 · 总被引 4054 次 · h-index 33

代表论文

• Dietary Strategies to Modulate Gut Microbiota in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (2025 · Nutrients · 被引 16)
• Predicting hepatic decompensation using non-invasive tests in a contemporary multicentre cohort of patients with cACLD (2025 · Journal of Hepatology · 被引 5)
• Impact of first and further decompensation in patients with compensated ACLD due to MASLD (2025 · Journal of Hepatology · 被引 5)
• Assessing Europe's policy readiness to confront the MASLD/MASH public health threat (2026 · The Lancet Regional Health - Europe · 被引 4)
• AISF practice guidance on pharmacological treatment of metabolic-dysfunction associated steatotic liver disease and steatohepatitis (MASLD/MASH): A 2026 Update (2026 · Digestive and Liver Disease · 被引 2)
• TOP-189-YI Vibration-controlled transient elastography of the liver and the spleen for hepatic decompensation risk stratification in a european multicentre study of contemporary cACLD patients (2025 · Journal of Hepatology · 被引 2)